High-dose chemotherapy in relapsed Hodgkin's lymphoma patients

被引：0
|
作者：
Belyaeva, E. [1 ]
Dolgopolov, I. [1 ]
Popa, A. [1 ]
Boyarshinov, V. [1 ]
Pimenov, R. [1 ]
Morozova, O. [1 ]
Visochin, I. [1 ]
Mentkevich, G. [1 ]
机构：
[1] Inst Ped Oncol Hematol, Moscow, Russia
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [31] Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis
    Nieto, Yago
    Gruschkus, Stephen
    Valdez, Benigno C.
    Jones, Roy B.
    Anderlini, Paolo
    Hosing, Chitra
    Popat, Uday
    Qazilbash, Muzaffar
    Kebriaei, Partow
    Alousi, Amin
    Saini, Neeraj
    Srour, Samer
    Rezvani, Katayoun
    Ramdial, Jeremy
    Barnett, Melissa
    Gulbis, Alison
    Shigle, Terri Lynn
    Ahmed, Sairah
    Iyer, Swaminathan
    Lee, Hun
    Nair, Ranjit
    Parmar, Simrit
    Steiner, Raphael
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Gunther, Jillian
    Cuglievan, Branko
    Mahadeo, Kris
    Khazal, Sajad
    Chuang, Hubert
    Champlin, Richard
    Shpall, Elizabeth J.
    Andersson, Borje S.
    HAEMATOLOGICA, 2022, 107 (04) : 899 - 908
  • [32] Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study
    Castagna, Luca
    Magagnoli, Massimo
    Balzarotti, Monica
    Sarina, Barbara
    Siracusano, Licia
    Nozza, Andrea
    Todisco, Elisabetta
    Bramanti, Stefania
    Mazza, Rita
    Russo, Filippo
    Timofeeva, Inna
    Santoro, Armando
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (02) : 122 - 127
  • [33] High-dose chemotherapy and autologous stem cell transplantation for relapsed Hodgkin's disease.
    Fetscher, S
    Waller, CF
    Technau, K
    Wild, Y
    Lange, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S104 - S104
  • [34] High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma
    S. Akhtar
    T. A. M. Elhassan
    W. Edesa
    M. S. Rauf
    M. N. Zahir
    I. Maghfoor
    Annals of Hematology, 2016, 95 : 49 - 54
  • [35] High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma
    Akhtar, S.
    Elhassan, T. A. M.
    Edesa, W.
    Rauf, M. S.
    Zahir, M. N.
    Maghfoor, I.
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 49 - 54
  • [36] High-dose sequential (RDS) chemotherapy with high-dose ARA-C and Rituximab prolongs the survival of patients with resistant/relapsed B-cell non-Hodgkin's lymphoma.
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Bellavita, P
    Motta, T
    Barbui, T
    BLOOD, 2002, 100 (11) : 646A - 646A
  • [37] Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma - Results of a large multicenter study of the German Hodgkin lymphoma study group (GHSG).
    Josting, A
    Rudolph, C
    Mapara, M
    Glossmann, JP
    Sieber, M
    Kirchner, HH
    Doerken, B
    Hossfeld, DK
    Kisro, J
    Metzner, B
    Berdel, WE
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 402A - 402A
  • [38] The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
    Beard S.M.
    Lorigan P.C.
    Sampson F.C.
    British Journal of Cancer, 2000, 82 (1) : 81 - 84
  • [39] Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma:: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
    Josting, A
    Rudolph, C
    Mapara, M
    Glossmann, JP
    Sienawski, M
    Sieber, M
    Kirchner, HH
    Dörken, B
    Hossfeld, DK
    Kisro, J
    Metzner, B
    Berdel, WE
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 116 - 123
  • [40] Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma:: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
    Josting, A
    Haverkamp, H
    Raemackers, J
    Diehl, V
    Dörken, B
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 : 302 - 302
12345